We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New OnTrak Multi-Drug Panel

By HospiMedica staff writers
Posted on 20 Sep 2005
Five new multi-drug panel configurations are available for the existing OnTrak TesTcard product line of rapid in vitro diagnostics. More...


The new panel enables test administrators to choose from a menu of various screens (3, 4, 5, and 6 drug panels), providing more flexibility while reducing time and costs. TesTcard can be administered in one of two ways: as a single-step dip-and-read test or as a single-step pipette test. Both methods require no reagent mixing, timing, incubation, or special handling. A patented design incorporates unique latex technology that provides results in three to five minutes and can be interpreted for up to six hours. The new panels are the products of Varian, Inc. (Palo Alto, CA, USA).

"Many of our customers will appreciate the flexibility TesTcard offers, providing them with a quality solution that doesn't compromise the quality of their drug-testing program,” remarked Stephen Schultheis, consumable products vice president and general manager, Varian. "TesTcard's various menu options enable testing to be done for relevant drugs in an affordable and efficient manner.”




Related Links:
Varian

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Patient Preoperative Skin Preparation
BD ChloraPrep
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.